We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

75 hedge funds and large institutions have $84.3M invested in Cascadian Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $94K | Put options by funds: $55K

18% more capital invested

Capital invested by funds: $71.2M → $84.3M (+$13.1M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 80 → 75 (-5)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
17
Reduced
21
Closed
22
Calls
$94K
Puts
$55K
Net Calls
+$39K
Net Calls Change
-$446K

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$28.3M
2
NMC
NEA Management Company
Maryland
+$12.2M
3
ACA
Avoro Capital Advisors
New York
+$1.9M
4
EAM
EverPoint Asset Management
Connecticut
+$1.7M
5
Millennium Management
Millennium Management
New York
+$721K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.48M
2
State Street
State Street
Massachusetts
-$1.77M
3
GCM
Gruss Capital Management
New York
-$1.41M
4
Northern Trust
Northern Trust
Illinois
-$1.01M
5
BIT
BlackRock Institutional Trust
California
-$902K
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Telemetry Investments
New York
$236K -$29.4K -4,333 -9%
ARTA
27
A.R.T. Advisors
New York
$213K +$152K +22,413 +146%
BA
28
BlackRock Advisors
Delaware
$196K -$38.7K -5,693 -14%
DCM
29
DAFNA Capital Management
California
$165K +$198K +29,167 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$158K – – –
Northern Trust
31
Northern Trust
Illinois
$125K -$1.01M -148,622 -87%
AGM
32
Alpine Global Management
New York
$121K +$145K +21,311 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$116K -$231K -34,070 -62%
CI
34
Cowen Inc
New York
$108K – – –
Squarepoint
35
Squarepoint
New York
$105K +$126K +18,533 New
BCM
36
Bridgeway Capital Management
Texas
$90K – – –
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$89K – – –
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$83K -$44.4K -6,539 -31%
Stifel Financial
39
Stifel Financial
Missouri
$79K – – –
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$76K +$14.2K +2,092 +18%
ProShare Advisors
41
ProShare Advisors
Maryland
$67K -$12.1K -1,781 -13%
State Street
42
State Street
Massachusetts
$63K -$1.77M -260,094 -96%
OAM
43
Oxford Asset Management
United Kingdom
$60K +$46.5K +6,845 +185%
Bank of America
44
Bank of America
North Carolina
$51K +$58.9K +8,676 +2,314%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$46K – – –
TRCT
46
Tower Research Capital (TRC)
New York
$45K +$53.8K +7,922 New
VKH
47
Virtu KCG Holdings
New York
$43K -$54.2K -7,978 -51%
Morgan Stanley
48
Morgan Stanley
New York
$42K +$8.42K +1,240 +20%
HPWM
49
Highland Private Wealth Management
Washington
$33K +$39.6K +5,833 New
DADC
50
D.A. Davidson & Co
Montana
$29K +$9.71K +1,430 +38%
1
2
3 4

CASC Hedge Fund Activity: Q2 2016 in Review

75 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q2 2016, worth a combined $84.3M — up 18% from $71.2M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CASC and 18 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 17 added.

The largest buyer was Baupost Group, opening a new position worth an estimated $28.3M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.48M.

  • 75 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q2 2016, down from 80 in Q1 2016.
  • Funds reported $84.3M of Cascadian Therapeutics, Inc. stock for Q2 2016, up 18% quarter-over-quarter.
  • 18 funds opened new Cascadian Therapeutics, Inc. positions in Q2 2016 and 22 closed out, a net change of -4 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q2 2016 was Baupost Group, an estimated $28.3M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q2 2016 was BlackRock Fund Advisors, an estimated $2.48M sold.

Based on aggregated 13F filings for Q2 2016.